HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Targeted therapy for cancer: the gastrointestinal stromal tumor model.

Abstract
Gastrointestinal stromal tumors (GISTs) are unique tumors, arising largely due to oncogenic mutations in KIT or PDGFRA tyrosine kinases. Although surgery remains the most effective treatment, the remarkable clinical success achieved with kinase inhibition has made GIST one of the most successful examples of targeted therapy for the treatment of cancer. The insight gained from this approach has allowed a deeper understanding of the molecular biology driving kinase dependent cancers, and the adaptations to kinase inhibition, linking genotype to phenotype. Mutation tailored kinase inhibition with second generation TKI's, and combination immunotherapy to harness the effects of TKIs remain exciting areas of investigation.
AuthorsVinod P Balachandran, Ronald P Dematteo
JournalSurgical oncology clinics of North America (Surg Oncol Clin N Am) Vol. 22 Issue 4 Pg. 805-21 (Oct 2013) ISSN: 1558-5042 [Electronic] United States
PMID24012400 (Publication Type: Journal Article, Review)
CopyrightCopyright © 2013 Elsevier Inc. All rights reserved.
Chemical References
  • Antineoplastic Agents
  • Protein Kinase Inhibitors
  • Protein-Tyrosine Kinases
Topics
  • Animals
  • Antineoplastic Agents (therapeutic use)
  • Gastrointestinal Stromal Tumors (drug therapy)
  • Humans
  • Molecular Targeted Therapy
  • Protein Kinase Inhibitors (therapeutic use)
  • Protein-Tyrosine Kinases (antagonists & inhibitors)
  • Signal Transduction (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: